Adipocyte-derived Exosomal MiR-22-3p Modulated by Circadian Rhythm Disruption Regulates Insulin Sensitivity in Skeletal Muscle Cells
Overview
Authors
Affiliations
Circadian rhythm disruption leads to dysregulation of lipid metabolism, which further drive the occurrence of insulin resistance (IR). Exosomes are natural carrier systems that advantageous for cell communication. In the present study, we aimed to explore whether and how the exosomal microRNAs (miRNAs) in circulation participate in modulating skeletal muscle IR induced by circadian rhythm disruption. In the present study, 24-h constant light (12-h light/12-h light, LL) was used to establish the mouse model of circadian rhythm disruption. Bmal1 interference was used to establish the cell model of circadian rhythm disruption. And in clinical experiments, we chose a relatively large group of rhythm disturbance-shift nurses. We showed that LL-induced circadian rhythm disruption led to increased body weight and visceral fat volume, as well as occurrence of IR in vivo. Furthermore, exosomal miR-22-3p derived from adipocytes in the context of circadian rhythm disruption induced by Bmal1 interference could be uptaken by skeletal muscle cells to promote IR occurrence in vitro. Moreover, miR-22-3p in circulation was positively correlated with the clinical IR-associated factors. Collectively, these data showed that exosomal miR-22-3p in circulation may act as potential biomarker and therapeutic target for skeletal muscle IR, contributing to the prevention of diabetes in the context of rhythm disturbance.
The Role of microRNA-22 in Metabolism.
Tomasini S, Vigo P, Margiotta F, Scheele U, Panella R, Kauppinen S Int J Mol Sci. 2025; 26(2).
PMID: 39859495 PMC: 11766054. DOI: 10.3390/ijms26020782.
Muscle-derived extracellular vesicles mediate crosstalk between skeletal muscle and other organs.
Jia J, Wang L, Zhou Y, Zhang P, Chen X Front Physiol. 2025; 15():1501957.
PMID: 39844898 PMC: 11750798. DOI: 10.3389/fphys.2024.1501957.
Zheng L, Rao Z, Wu J, Ma X, Jiang Z, Xiao W Int J Mol Sci. 2024; 25(22).
PMID: 39596482 PMC: 11595072. DOI: 10.3390/ijms252212416.
Fekry B, Ugartemendia L, Esnaola N, Goetzl L Cancers (Basel). 2024; 16(14).
PMID: 39061191 PMC: 11274441. DOI: 10.3390/cancers16142552.